Based on an updated analysis of adverse events reported to the FDA and complications described in the scientific literature, the FDA identified surgical mesh for transvaginal repair of POP as an area of continuing serious concern.
San Diego, CA (PRWEB) April 25, 2013
San Diego personal injury lawyer Melinda J. Helbock is announcing that she is investigating lawsuits on behalf of women who claim to have suffered injuries from transvaginal mesh products.
According to Melinda Helbock, she is available to review potential claims involving transvaginal mesh injuries such as bleeding, infection, organ perforation, erosion through the vagina and more.
The U.S. Food and Drug Administration (FDA) issued a safety communication on July 13, 2011 to notify health care providers about serious complications associated with transvaginal placement of surgical mesh for pelvic organ prolapse (POP) and stress urinary incontinence (SUI).*
The FDA said in its announcement that complications with transvaginal mesh are not rare.
“Based on an updated analysis of adverse events reported to the FDA and complications described in the scientific literature, the FDA identified surgical mesh for transvaginal repair of POP as an area of continuing serious concern,” the agency said.
According to the FDA, it received more than 1,000 reports of adverse events associated with surgical mesh products used to repair POP and SUI between 2005 and 2007. The agency said it received another 2,874 reports of complications between Jan. 1, 2008 and Dec. 31, 2010. Of those, 1,503 were reports of injuries in POP patients and 1,371 were reports of injuries in SUI patients.
Attorney Melinda Helbock is announcing that she is reviewing possible transvaginal mesh lawsuits on behalf of POP and SUI patients who have suffered complications following surgery. To schedule a consultation, please call 1-858-794-1456.